Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|March 15, 2000
HIV-1 diversity in France, 1996-1998. The AC 11 laboratory networkE Couturier, F Damond, P Roques, et al.
The American Journal of Gastroenterology|August 5, 2000
TT virus infection during chronic hepatitis CP Trimoulet, V de Lédinghen, D Ekouevi, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1987
[Particles with retrovirus appearance and reverse transcriptase activity in cell cultures derived from lymph node biopsies in Hodgkin's disease]J Lesser, D Dormont, J M Tourani, et al.
Journal of Clinical Microbiology|September 17, 1999
Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patientsI Pellegrin, I Garrigue, C Binquet, et al.
HIV Medicine|March 18, 2011
Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patientsP Trimoulet, C Belzunce, M Faure, et al.
Virology|July 16, 1999
Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8D Lang, W Hinderer, M Rothe, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Structure-analysis of the HIV-1 integrase Y143C/R raltegravir resistance mutation in association with the secondary mutation T97AS Reigadas, B Masquelier, C Calmels, et al.
Antimicrobial Agents and Chemotherapy|October 23, 1997
Phosphorothioate oligonucleotides derived from human immunodeficiency virus type 1 (HIV-1) primer tRNALys3 are strong inhibitors of HIV-1 reverse transcriptase and arrest viral replication in infected cellsR El Dirani-Diab, L Sarih-Cottin, B Delord, et al.
Infection|February 14, 2007
Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritisJ F Viallard, E Lazaro, E Ellie, et al.
AIDS (London, England)|October 6, 1999
Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI GroupI Pellegrin, J Izopet, J Reynes, et al.
Pageof 7